These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19709074)

  • 1. The Shared Equal Access Regional Cancer Hospital (SEARCH) nomogram for risk stratification in intermediate risk group of men with prostate cancer: validation in the Duke Prostate Center database.
    Jayachandran J; Schroeck F; Sun L; Gerber L; Moreira DM; Moul JW; Freedland SJ
    BJU Int; 2010 Jan; 105(2):180-4. PubMed ID: 19709074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Jayachandran J; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Stephenson AJ; Freedland SJ
    BJU Int; 2009 Nov; 104(10):1452-6. PubMed ID: 19466946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
    Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
    BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?
    Laudano MA; Lambert SM; Masson P; McCann TR; Desai M; Benson MC; McKiernan JM
    BJU Int; 2009 Feb; 103(3):317-20. PubMed ID: 18778341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
    Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
    J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology Society.
    Eskicorapci SY; Türkeri L; Karabulut E; Cal C; Akpinar H; Baltaci S; Baykal K; ; Kattan MW; Ozen H
    Urology; 2009 Dec; 74(6):1289-95. PubMed ID: 19589584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA; Cooperberg MR; Elkin EP; Lubeck DP; Mehta SS; Kane CJ; Carroll PR
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
    Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
    Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy].
    Graefen M; Augustin H; Karakiewicz PI; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Cagiannos I; Scardino PT; Kattan MW; Huland H
    Urologe A; 2003 May; 42(5):685-92. PubMed ID: 12750804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram.
    Thanigasalam R; Rasiah KK; Stricker PD; Haynes AM; Sutherland SI; Sutherland RL; Henshall SM; Horvath LG
    BJU Int; 2010 Mar; 105(5):642-7. PubMed ID: 19751263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue.
    Rabbani F; Vora KC; Yunis LH; Eastham JA; Guillonneau B; Scardino PT; Touijer K
    BJU Int; 2009 Sep; 104(5):605-10. PubMed ID: 19689577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.
    Isbarn H; Karakiewicz PI; Walz J; Ahyai SA; Steuber T; Haese A; Budäus L; Schlomm T; Eichelberg C; Heuer R; Heinzer H; Huland H; Graefen M; Chun FK
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):788-92. PubMed ID: 19818565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of risk factors for biochemical progression in patients with seminal vesicle invasion: validation of Kattan's nomogram in a pathological subgroup.
    Ramsden AR; Chodak G
    BJU Int; 2004 May; 93(7):961-4. PubMed ID: 15142143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
    Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percent tumor involvement and risk of biochemical progression after radical prostatectomy.
    Rampersaud EN; Sun L; Moul JW; Madden J; Freedland SJ
    J Urol; 2008 Aug; 180(2):571-6; discussion 576. PubMed ID: 18554662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
    Richstone L; Bianco FJ; Shah HH; Kattan MW; Eastham JA; Scardino PT; Scherr DS
    BJU Int; 2008 Mar; 101(5):541-6. PubMed ID: 18257855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy.
    Talantov D; Jatkoe TA; Böhm M; Zhang Y; Ferguson AM; Stricker PD; Kattan MW; Sutherland RL; Kench JG; Wang Y; Henshall SM
    J Urol; 2010 Oct; 184(4):1521-8. PubMed ID: 20723930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.